Background: Dermatophytes are the most prevalent pathogenic fungi globally, infecting an estimated 20-25% of the world's population. While classically recognized by annular, scaly plaques with central clearing, dermatophytes exhibit a remarkable and underappreciated clinical polymorphism. This chameleonic ability frequently leads to diagnostic confusion with a broad spectrum of inflammatory, autoimmune, and neoplastic skin diseases.

Objective: To systematically characterize the atypical morphological variants of superficial dermatophytosis that mimic other dermatoses and to provide a practical diagnostic framework to avoid misdiagnosis.

Methods: We present a descriptive case series of nine patients with culture-proven or KOH-confirmed dermatophyte infections, each initially misdiagnosed as a distinct dermatological entity. We review the underlying pathophysiological mechanisms—including host immune response, fungal strain variation, and the confounding effect of topical corticosteroid use (tinea incognito)—that contribute to these atypical presentations.

Results: Our series illustrates nine distinct mimetic patterns: (1) Alopecia Areata-Like Tinea Capitis, (2) Contact Dermatitis-Like Tinea Faciei, (3) Discoid Eczema-Like Tinea Corporis, (4) Tinea Imbricata-Like Concentric Scaling, (5) Folliculitis-Like Tinea Barbae/Corporis, (6) Lichen Planus Actinicus-Like Tinea, (7) Rosacea-Like Tinea Faciei, (8) Pustular Psoriasis-Like lesions on the groins and (9) Dermatitis Cosmetica like tinea on the face and neck. In all cases, the correct diagnosis was established only after mycological examination, leading to resolution with systemic or topical antifungal therapy.

Conclusion: Dermatophytosis has rightfully earned its place among the "Great Imitators" in dermatology. Failure to recognize these masqueraders results in prolonged morbidity, inappropriate immunosuppressive therapy, and increased healthcare costs. We propose a "Fungal-First" diagnostic algorithm and emphasize that any scaly, erythematous, or pustular eruption unresponsive to standard therapy warrants mycological investigation.